CBD Derivative

CBDB(CAS 60113-11-3)is an analytical reference standard categorized as a phytocannabinoid. CBDB has been found in strains of Cannabis and hemp. CBDB is considered an impurity in commercial extractions of cannabidiol (CBD) from hemp. This product is intended for research and forensic applications.

Cannabidihexol (CAS 2552798-21-5) is a novel phytocannabinoid derivative with promising analgesic and neuroprotective properties. While its pharmacological profile is promising, further research is needed to validate its therapeutic potential and optimize its pharmacokinetics.

Cannabidiphorol (CAS 55824-13-0) is a novel phytocannabinoid derivative with promising analgesic and neuroprotective properties. Its high lipophilicity and structural complexity present challenges in drug development but also offer opportunities for targeted therapeutic applications. 

CBGB (CAS 2468125-69-9) represents a novel organic compound with potential applications in pharmaceuticals or materials science. Its structural complexity and lack of explicit data highlight the need for further experimental characterization and regulatory review.

CBGAQ ​(CAS 2442482-70-2) is a key synthetic intermediate featuring a reactive diene core and a carboxylic acid functional group. It is primarily used in the synthesis of complex organic molecules, including cannabinoid precursors and other bioactive compounds.Cannabigerolic Acid Quinone (CBGAQ) is a unique, oxidized derivative of Cannabigerolic acid (CBGA), the central biosynthetic precursor to all major phytocannabinoids (like THCA, CBDA, CBCA). Structurally, CBGAQ is characterized by the conversion of the ​resorcinol (1,3-dihydroxybenzene) ring​ in CBGA into a ​para-quinone (2,5-dihydroxy-1,4-benzoquinone) moiety. This quinoid transformation significantly alters its chemical reactivity, redox potential, and biological activity, placing it in the emerging class of ​quinone cannabinoids.

Cannabielsoin(CBE)  (CAS 52025-76-0) is a phytocannabinoid derivative with potential analgesic and neuroprotective applications. Its structural complexity and lipophilicity present challenges in drug development but also offer opportunities for targeted therapeutic formulations.